Completed NA INTERVENTIONAL 3-arm NCT03580980

Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries

Evaluation of Multimodal Preemptive Analgesia in Major Pediatric Abdominal Cancer Surgeries

Sponsor: National Cancer Institute, Egypt

Conditions Pain, Postoperative Pediatric Cancer

Interventions Caudal levobupivacaine Morphine Paracetamol and ketamine

Updated 4 times since 2018 Last updated: Jul 9, 2018 Started: Apr 1, 2015 Primary completion: Nov 30, 2017 Completion: Nov 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Pain, Postoperative and Pediatric Cancer and is currently completed. National Cancer Institute, Egypt leads this study, which shows 4 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute, Egypt

Data source: National Cancer Institute, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt